Welcome to
Adcock Ingram
Our website offers information about our Company that will give you an understanding of who we are and what we do and how we are building a world class, leading, branded healthcare company. Please contact us should you require any further information on our products or services
to contact us click here
  • Adcock Ingram, a level four B-BBEE pharmaceutical company

  • A leading world-class branded healthcare company

  • Our commitment to quality drives our world-class manufacturing facilities

  • Adding value to life through our Corporate Social Investment programmes

  • Producing pharmaceutical products in the most environmentally friendly way

Latest News

Current News

jse top stocks

...NG SA CORPORATE REAL EST SUPER GROUP LTD NAMPAK LTD RCL FOODS LTD/SO GRINDROD LTD PPC LTD SUN INTERNATIONAL WILSON BAYLY HOLMES ADCOCK INGRAM HOLD LONMIN PLC ROYAL BAFOKENG PLAT EMIRA PROPERTY FUND~~ REBOSIS PROPERTY RHODES FOOD GROUP CITY LODGE HOTELS AS...

read more..


How much is enough to hold offshore in 2017

...o invest in the Pharmaceutical Sector on the FTSE/JSE; the options are limited to three companies, namely Aspen, Ascendis and Adcock Ingram. However within global markets, there is a selection of over 60 pharmaceutical companies, and that’s just on the Lo...

read more..


6 top South African stock picks for 2017

...at Sanlam Private Wealth also provided a list of three shares he expects to be ‘attractive picks’ in 2017: Adcock Ingram This business has strong household names in both its over-the- counter (OTC) and consumer brands divisions, according to McNamar...

read more..


Eish, it’s lekker when billboards talk the lingo

...dvisor to Primedia Outdoor. Using the right terms can be crucial in getting your point across, as Minanawe’s work for Adcock Ingram painkillers has demonstrated: When a target audience just didn’t get the original outdoor text - ‘From Ow Ow to Wow Wow’ - ...

read more..


Lindsay Ralphs, Non-executive Director, Adcock Ingram

Lindsay Ralphs is a Non-independent non-executive director of Adcock Ingram , he was appointed on the 24th of November 2016. He is the CEO of The Bidvest Group Limited since May 2016. Director of numerous Bidvest subsidiaries, Chairman of Bidvest Sout...

read more..


Finance committee has work cut out

PUBLIC HEARINGS Finance committee has work cut out Linda Ensor Political Writer Parliament's standing committee on finance has an intensive series of public hearings lined up when committees begin work next week, most controversially regarding the constit...

read more..


Brian Rogers: “I have a dream for SA in 2017…”

Actually, I have a dream for the next thirty years which starts in 2017. That is, we institute action plans to eradicate childhood abuse in South Africa. It is an intergenerational issue, so bearing in mind that 35.4% of our children have suffered some fo...

read more..


Pharma forecast: 2017 a big year for generics

A positive outlook on a tough year for business 11 January 2017 According to National Treasury, the GDP growth rate is forecasted at an estimated 1.3% for 2017. The outlook points to a tough year ahead for business; however, there are a few trends that

read more..


Finance committee has work cut out

The committee has called for written submissions on the Fica bill, as well as the sugar tax and insurance bills Parliament’s standing committee on finance has an intensive series of public hearings lined up when committees begin work next week, most contr...

read more..


Medical cannabis – myths vs facts

SAMA warns that the proposed amendments to allow for medical marijuana will be implemented along strict guidelines The South African Medical Association (SAMA) notes the significant developments made in relation to medical cannabis in South Africa. Ho...

read more..


Contact Medical Affairs or report an Adverse Event

To contact medical affairs or to report an adverse event
click here

News and Media

For the latest Adcock Ingram news
click here

Careers

For careers that add value to people’s lives
click here

Financial Results

Online Group Audited Results Booklet 2016
click here

Products

For more information on our products
click here

Financial Indicators

Latest Share Price
4834 cents
Percentage Change: -1.71
Code: AIP
PE Ratio: 21.14
EY: 4.73
DY: 2.15
ZAR/USD: 13.5773
Interim Dividend (cents): 50.00
Final Dividend (cents): 54.00
30 day vwap
4864 cents